click below
click below
Normal Size Small Size show me how
usmle world q
Question | Answer |
---|---|
hydroxychloroquine SE | permanent retinal damage |
se of methotrexate | mouth ulcers, hepatitis, fibrosis, cirrhosis, myelosuppression, increased risk for opp. infxns, B cell lymphoma, pulm fibrosis. |
tx for abscess in lung | clindamycin to cover anaerobes |
MOA of ethambutol | inhibits carbohydrate polymerization -> prevents peptidoglycan cell wall synthesis |
side effect of ethambutol | optic neuritis, decreased visual acuity, central scotoma, color blindness |
mech of resistance of rifampin | spontaneous genetic mutations of the bacterial DNA dependent RNA polymerase |
painless hematuria 2-3 days after an URI | IGA nephropathy- berger disease |
unmineralized spongiosa in medullary canals | osteopetrosis |
osteoid matrix accumulation around trabeculae | rickets |
drugs that prolong QT | macrolides (block K+ channels); flunconazol; class 1A, 1C, 3 antiaryhtmics |
conditions that prolong QT | liver disease ( increase toxicity of drugs), hypokalemia, hypomagnesemia, hypocalcemia, acidosis, heart failure, hypoxia |
WPW | shortened PR interval, widened QRS, delta wave which signifies early depolarization |
alpha 1 blocker associated with first dose resoponse orthostatic hypotension | prazosin |
selective alpha 2 blocker | mirtazipine for depression |
alpha 1 and alpha 2 | phenoxybenzamine and phentolamine |
sotalol | beta blocker and potassium channel blocker |
labetalol | alpha and beta blocker |
carvedilol | alpha and beta blocker |
non depolarizing NMJ blockers | curoniums - Rocuronium |
depolarizing NMJ blocker | succinylcholine |
receptor that decreases insulin release | alpha 2 |
receptor that increases renin | beta 1 |
increases lipolysis via HSL (hormone sensitive lipase) | beta 1 |
relaxes uterus | beta 2 |
increases liver glycogenolysis and gluconeogenesis | beta 2 |
inhibits mast cell release | beta 2 |
↑ gastric acid secretion, found in CNS | M1 |
decreases HR, decreases contractility, decreases AV node conduction | M2 |
increases peristalsis, increases bladder contraction, increases exocrine gland secretions, bronchoconstriction, contracts the sphincter pupillae (miosis) | M3 |
renal vasodilation | D1 |
dopamine control in brain | D2 |
mast cell degranulation, nasopharyngeal/bronchial mucus production, bronchial vasoconstriction. | H1 |
increases vascular smooth muscle contraction | V1 |
increases gastric acid secretion | H2 |
vasopressin receptor in collecting tubules ↑ H2O reabsorption | V2 |
vasoconstriction, constricts uterus, contracts pupillary dilator (mydriasis), constricts sphincters in intestine as well as internal urethral sphincter | alpha 1 |
location of CYP450 | inner membrane of mitochondria or smooth endoplasmic reticulum |
Drugs that induce P450 (and are ∴ contraindicated in porphyrias! | Barb-E Steals Smokin Phen-phen, INDUCES vomiting, and Refuses Greasy Gluttonous Carbs Chronically" |
CYP450 substrates | substrates: Acetaminophen, Warfarin, numerous Cardiovascular drugs |
tardive dyskinesia | metoclopromide, antipsychotics |
disulfiram like rxn | Metronidazole; Sulfonylureas, 1st generation; Griseofulvin; Some cephalosporins Procarbazine |
cholinergic syndrome | Cholinesterase inhibitors: neostigmine, physostigmine; Organophosphates (Sarin, Soman); Cholinomimetics: Pilocarpine, Carbachol, Bethanechol |
anticholinergic syndrome | "All These Quirks Are Muscarinic Antagonists": Antipsychotics, TCAs, Quinidine, Amantadine, Meperidine, Antihistamines |